Has Eugene Rubach, MD received payments from drug or device companies?

Yes. Drug and device makers reported $90,059 in general payments to Eugene Rubach, MD across 166 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eugene Rubach, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eugene Rubach, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eugene Rubach, MD

Surgery · Manhasset, NYNPI 1881692200

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $60,209 of the $90,059 with a category attached, or 66.9%. 27 manufacturers reported payments, led by Covidien LP at 42.2% of the total. Reporting peaked in 2020 at $35,365 and has fallen 80.0% since, to $7,073 in 2025. Among surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,059in general payments, 2019–2025

Across 166 payments — averaging $542.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Covidien LP$38K
Medtronic$36K
TELA Bio, Inc.$7K
Johnson & Johnson$2K
Medical Device Business Services, Inc.$2K
Stryker$505
plus $5K from 21 others

What the payments were for

Consulting fees$18,04920%
Speaking & faculty fees$60,20967%
Travel & lodging$1,9762%
Food & beverage$9,77511%
Education$500%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Covidien LP	16	$38,029
Medtronic(2 entities)	32	$35,912
TELA Bio, Inc.	21	$6,732
Johnson & Johnson(2 entities)	29	$2,371
Medical Device Business Services, Inc.	14	$1,984
Stryker	2	$505
Kestra Medical Technology Services, Inc.	4	$489
Abbott	3	$462
Boston Scientific	3	$392
Applied Medical Resources Corporation	1	$375
Intuitive Surgical	3	$306
Vertex	2	$272
Integra Lifesciences Corporation	1	$271
Merck	12	$245
Conmed Corporation	1	$239
Olympus America Inc.	2	$208
Biotronik Inc.	2	$169
Enterra Medical, Inc.	1	$152
Ethicon Endo-surgery Inc.	1	$150
Guard Medical Inc.	1	$143
Cumberland Pharmaceuticals, Inc.	8	$138
Activ Surgical, Inc.	1	$137
Baxter Healthcare	1	$122
W. L. Gore & Associates, Inc.	1	$101
Davol Inc.	1	$100
Chiesi USA, Inc.	2	$39
Galvanize Therapeutics, Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AbsorbaTack$34,956
ProGrip$6,525
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$5,990
HARMONIC Product Family$1,085
ECHELON ENDOPATH Stapler$1,085
INTEGRA$814
VersaOne$813
Echelon Flex$616
Assure WCD$449
Megadyne$398
SPY-PHI SYSTEM$385
Quadra Assura CRT Defibrillator$337
Abre$334
OviTex 2S$275
INTEGRA DERMAL REGENERATION TEMPLATE$271
PRIMATRIX$271
ECHELON ENDOPATH$271
VISICLEAR$239
AIRSEAL$239
NEUWAVE Flex Microwave Ablation System$227

How this compares

$90,059 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York →

Medicare billing

Part B allowed, 2024

$314,259

Medicare patients

453

Services billed

965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Manhasset

George DenotoManhasset$333K
Cheguevara AfanehNew York$1.4M
Flavio Malcher Martins de OliveiraNew York$695K
Yuri NovitskyNew York$548K
Rasa ZarnegarNew York$478K
Tanuja DamaniNew York$459K
Benjamin SadowitzSyracuse$419K
Stephen GoldstoneNy$386K
Rache SimmonsNew York$371K
Marina KurianNew York$328K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →